The leading medical device company Johnson & Johnson Medical Devices (JJMD), announced partnership with 100 Open Startups, and launched Value-Based Health Care 2.0, which invited startups from all over Latin America to develop an integrated digital platform that automates the entire patient care journey.
The partnership will stimulating the development of solutions that help the health value chain to implement new models of value-based health care
The Value-Based Health Care 2.0 challenge attracted more than 130 startups, who forwarded their value-based care solutions to the JJMD team.
The prominent acquisitions by Johnson & Johnson are featured below:
Aug 2020: Johnson & Johnson announced that it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc., for approximately $6.5 billion. Momenta Pharmaceuticals, Inc., a company that discovers and develops novel therapies for immune-mediated diseases.
April 2020: Johnson & Johnson announced that Janssen Pharmaceutical has collaborated with Emergent BioSolutions, Inc. to support the manufacturing of its lead investigational COVID-19 vaccine candidate. The collaboration will help to accelerate manufacturing of COVID-19 vaccine candidate, and further help to supply more than one billion doses of the vaccine worldwide.
April 2020: Johnson & Johnson announced its supports to the American Nurses Foundation; the Covid-19 Solidarity Response Fund, which will support the World Health Organizations work to prevent, detects and responds to the pandemic. The company has committed to provide a $50 million support to healthcare workers of front lines across the world.
March 2020: Johnson & Johnson announced that its subsidiary company, Janssen Pharmaceutical has collaborated with the Beth Israel Deaconess Medical Center (BIDMC) to support the development of a preventive vaccine candidate for COVID-19. With this collaboration Janssen will initiate a Phase 1 clinical study of a potential vaccine candidate.
About Johnson & Johnson
Johnson & Johnson, headquartered in New Brunswick, United States is a global pharmaceutical and medical device company. The company with experience of more than 130 years and employing 130,000 is blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.